Rui Huang

19PUBLICATIONS
24CO-AUTHORS
Cellular immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 30, 2026
Immune Checkpoint Inhibitor-Induced Myelitis Presenting with "Hot Cord" Sign on 18F-FDG PET/CT: A Case Report.

|Sep 28, 2026
The impact of RET fusions on radioiodine avidity and prognosis in patients with distant metastatic papillary thyroid cancer.

|Aug 21, 2026
Exploration of Chemokine Receptor 4 Targeted [68Ga]Ga-pentixafor PET/CT in Radioiodine-refractory Differentiated Thyroid Cancer.

|Apr 01, 2026
BRAF/MEK inhibitors for redifferentiation in patients with radioiodine refractory thyroid cancer: A systematic review and Meta-Analysis.

Kexin Shi, Xinyue Zhang, Chenyu Sun

|Dec 16, 2025
Rosai-Dorfman Disease Involving Thymus and Aorta Revealed by 18 F-FDG PET/CT.

Mengfang Qi, Junjun Cheng, Hongyuan Dai

|Sep 03, 2025
Development of Novel Peptide-Based 68Ga-Labeled Radiotracers for Detecting ROR1 Expression in Tumors.

Shuhui Huang, Tian Tian, Mengfang Qi

Pageof 4

Frequent Collaborators

3 joint publications

Tian Tian

3 joint publications

Minggang Su

2 joint publications

Xiaoai Wu

2 joint publications

Yanlin Liu